Olr22 Activators
Olr22 activators encompass a diverse set of molecules primarily targeting G-protein coupled receptor (GPCR) modulation and associated pathways. Olfactory receptors like Olr22 belong to the GPCR family, and their activation often depends on the specific binding of odorant molecules. In the absence of direct odorant activators, other chemicals influencing GPCR signaling can be considered for potential activation. One of the central mechanisms to achieve this is through the modulation of intracellular cAMP levels. Compounds like Forskolin, which activate adenylyl cyclase, elevate cAMP levels, and can indirectly stimulate GPCRs like Olr22. Similarly, IBMX, a PDE inhibitor, maintains elevated cAMP levels, further potentiating GPCR activation.
Other compounds in the list, including Isoproterenol, L-741,626, and Anandamide, are direct agonists or antagonists of specific GPCRs. While they don't directly activate Olr22, their method of action provides a foundation for understanding potential mechanisms to influence Olr22. Furthermore, these molecules' interactions with GPCRs, whether they're adrenergic, dopamine, or cannabinoid receptors, showcase the intricate nature of GPCR signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases (PDEs), preventing the degradation of cAMP. By maintaining higher intracellular cAMP levels, GPCR signaling pathways such as those for Olr22 can be enhanced and made more sensitive to their activating odorants. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
While Isoproterenol is a beta-adrenergic receptor agonist, its activation of these receptors and associated increase in intracellular cAMP can provide a more favorable environment for the activation of nearby GPCRs like Olr22 when they encounter their odorants. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
By inhibiting adenylyl cyclase, SQ 22536 reduces cAMP levels. This may lead to a compensatory upregulation of other pathways or receptors, including Olr22, to maintain cellular homeostasis. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $67.00 $286.00 $1326.00 | 11 | |
As a GABA receptor antagonist, Picrotoxin's modulation of GABA signaling might indirectly influence the balance of neurotransmitter signaling. This change can possibly shift the cellular environment to favor Olr22 activation when its specific odorants are present. | ||||||
Almorexant | 871224-64-5 | sc-507322 | 10 mg | $330.00 | ||
As an orexin receptor antagonist, Almorexant's influence on the orexin pathway might indirectly promote a state where Olr22 is more responsive to its activating odorants due to cross-talk between GPCR pathways. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine acts as an antagonist to alpha-2 adrenergic receptors. Its modulation of adrenergic signaling can indirectly shape a cellular milieu where Olr22 activation is more likely upon exposure to its odorants. | ||||||
ZM 241385 | 139180-30-6 | sc-361421 sc-361421A | 5 mg 25 mg | $92.00 $356.00 | 1 | |
As an antagonist for A2A adenosine receptors, ZM 241385's modulation of purinergic signaling can indirectly result in a cellular environment where Olr22 becomes more responsive to its activating odorants. | ||||||